✦ LIBER ✦

Engraftment kinetics and hematopoietic chimerism after reduced-intensity conditioning with fludarabine and treosulfan before allogeneic stem cell transplantation

✍ Scribed by I. W. Blau; Martin Schmidt-Hieber; N. Leschinger; H. Göldner; W. Knauf; W. Hopfenmüller; E. Thiel; O. Blau

Book ID: 105988942
Publisher: Springer
Year: 2007
Tongue: English
Weight: 152 KB
Volume: 86
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-007-0294-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prospective phase II trial to evaluate t

Prospective phase II trial to evaluate the complications and kinetics of chimerism induction following allogeneic hematopoietic stem cell transplantation with fludarabine and busulfan

✍ Akiko M. Saito; Masahiro Kami; Shin-Ichiro Mori; Yoshinobu Kanda; Ritsuro Suzuki 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB 👁 2 views

Allogeneic stem cell transplantation aft

Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia

✍ N. Kröger; M. Bornhäuser; G. Ehninger; R. Schwerdtfeger; H. Biersack; H. G. Saye 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 201 KB

Successful engraftment and stable full d

Successful engraftment and stable full donor chimerism after myeloablation with thiotepa, fludarabine, and melphalan and CD34-selected peripheral allogeneic stem cell transplantation in hemophagocytic lymphohistiocytosis

✍ Simone Cesaro; Maria Vittoria Gazzola; Piero Marson; Elisabetta Calore; Luciana 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB 👁 1 views

Immune hemolysis after fludarabine-based

Immune hemolysis after fludarabine-based reduced intensity conditioning and allogeneic PBSC transplantation for CML with minor ABO incompatibility

✍ Rodolfo Calixto; Fabiana Ostronoff; Mauricio Ostronoff; Alexandre Sucupira; Rodr 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 101 KB

Risk factor analysis for thrombotic micr

Risk factor analysis for thrombotic microangiopathy after reduced-intensity or myeloablative allogeneic hematopoietic stem cell transplantation

✍ Hirohisa Nakamae; Takahisa Yamane; Taro Hasegawa; Mika Nakamae; Yoshiki Terada; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB 👁 1 views

Allogenic hematopoietic stem-cell transp

Allogenic hematopoietic stem-cell transplantation with reduced-intensity conditioning in patients with refractory and recurrent multiple myeloma : Long-term follow-up

✍ Avichai Shimoni; Izhar Hardan; Francis Ayuk; Georgia Schilling; Djorde Atanackov 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB

## Abstract ## BACKGROUND: Allogeneic stem cell transplantation (SCT) with myeloablative conditioning is potentially curative therapy for myeloma, but is reportedly associated with a high risk of nonrecurrence mortality (NRM). Reduced‐intensity conditioning (RIC) allows for the reduction of NRM, b